Background: Lung function is dependent upon the regulation of tissue and alveolar lipids. Results: Activation of SREBP in alveolar cells caused neutral lipid accumulation, inflammation, and tissue remodeling.
teins causes respiratory distress syndrome in neonates and participates in the pathogenesis of acute lung injury in adults. The fibrosing sequellae that often accompany these syndromes can cause chronic respiratory insufficiency. Lack of pulmonary surfactant, related to mutations in genes critical for surfactant synthesis and activity, causes both acute respiratory failure and life-threatening chronic lung disorders, including pulmonary fibrosis (1) (2) (3) (4) . Conversely, excess accumulation of surfactant lipids occurs in the lungs of patients with pulmonary alveolar proteinosis, a disorder caused by defects in GM-CSF signaling that impair clearance of surfactant by alveolar macrophages (5) . Lipid storage diseases are often accompanied by chronic inflammation and fibrosing alveolitis (6, 7) .
The abundance and composition of lung lipids are precisely regulated. Pulmonary surfactant is enriched in phosphatidylcholine (PC) 3 and phosphatidylglycerol that play important roles in reduction of surface tension. Surfactant PC is relatively enriched in saturated species. Although cholesterol is present in varying quantities in mammalian surfactants, excess cholesterol impairs the surface tension reducing properties of surfactants (8) . Triacylglycerols, an important storage form of lung lipids, are normally present in small amounts in alveolar tissues and are thought to serve as substrates for phospholipid synthesis by alveolar type 2 cells during development (9) . The role of neutral lipid pools in surfactant lipid homeostasis has not been clearly defined in the adult lung. Surfactant lipid composition and abundance are influenced by lung injury, likely mediated by intracellular and extracellular processes that control synthesis and catabolism of lipids present in pulmonary surfactant (10) . Thus, a complex regulatory system has evolved to precisely control lung lipid content and composition in the alveolus.
Lung lipid homeostasis is regulated by multitiered processes influencing 1) the uptake of lipids from the systemic circulation, 2) synthesis and storage of lipids by epithelial and stromal compartments in the alveolus, and 3) secretion, reuptake, reutilization, and catabolism of surfactant lipids, which together precisely control intracellular and extracellular surfactant pools before and after birth. As in other tissues, lipid homeostasis in the lung is influenced, in part, by sterol-regulatory element-binding proteins (SREBPs). SREBP1c expression increases before birth in association with increased lipogenesis in type 2 epithelial cells (11) . Deletion of the Scap gene (encoding the SREBP cleavage-activating protein) inhibited SREBP activity in type 2 cells and enhanced neutral lipid accumulation in lung fibroblasts in the fetal and postnatal mouse lung (12) , demonstrating important roles for the SREBP pathway in lung lipid homeostasis.
SREBP is activated at the post-transcriptional level by SCAP. SCAP serves as a lipid sensor that in the absence of sterols/ phospholipids transports SREBPs from the endoplasmic reticulum to the Golgi where S1P and S2P proteases release a transcriptionally active N-terminal fragment of SREBP. Conversely, SREBP activity is inhibited by insulin-induced gene proteins 1 and 2 that anchor the SCAP-SREBP complex to the endoplasmic reticulum membrane in a lipid-dependent manner. Insig1 and Insig2 share structural similarities and have partially redundant functions (13) . Although germ line deletion of Insig1 in the mouse caused death at birth, germ line deletion of Insig2 did not influence survival. Deletion of both Insig genes in hepatic tissues increased transcription of SREBP target genes causing accumulation of cholesterol and triglycerides (13) . There is increasing evidence that the accumulation of lipid droplets in various tissues during substrate excess causes tissue inflammation and is inhibited in part by the recruitment and activation of tissue macrophages (14) .
This study was designed to further define the roles of SREBP and insulin-induced genes in the regulation of lung lipid homeostasis and to test whether enhanced lipogenesis influenced surfactant homeostasis, lung lipid content, or lung inflammation. Deletion of Insig1 and -2 induced SREBP1 in alveolar type 2 cells, causing neutral lipid accumulation in type II cells and in the alveoli. The accumulation of lung lipids caused inflammation and airspace remodeling with pathological findings similar to those associated with lipid storage disorders, diabetes mellitus, and obesity. (15) . Genotypes were identified by PCR from genomic tail DNA as described previously (13, 16) .
EXPERIMENTAL PROCEDURES
Animal Husbandry and Doxycycline Administration-Mice were maintained in a pathogen-free environment in accordance with protocols approved by the Institutional Animal Care and Use Committee of Cincinnati Children's Hospital Research Foundation. Gestation was dated by detection of the vaginal plug, and dams bearing pups carrying the Insig1 flox allele were maintained on doxycycline in food (625 mg/kg dry weight; Harlan Teklad, Madison, WI) from embryonic days 6.5 to 12.5 to delete Insig1 in progenitor cells that form the peripheral lung and to minimize effects of Cre-recombinase (Cre) or reverse tetracycline transactivator that can occur later in gestation. Mice were killed at 2, 6, and 8 months of age for study.
Preparation of Tissue for Morphologic Analysis-Mice were killed by overdose of anesthetic and exsanguinated by sectioning the abdominal aorta. The anterior thoracic wall was removed. The trachea was cannulated, and the lungs were inflated at a pressure of 25 cm of H 2 O with 4% paraformaldehyde in phosphate-buffered saline for 1 min. The trachea was ligated, and the heart and lungs were removed and immersed in the same fixative at 4°C for 18 h. After three rinses in cold PBS, the right lung and the upper half of the left lung were dehydrated in graded ethanol and embedded in paraffin; the lower half of the left lung was immersed in 30% sucrose in PBS for 24 h, immersed in a 2:1 mixture of 30% sucrose and OCT sectioning medium (Sakura, Torrance, CA) for another 24 h, and then embedded in OCT and stored at Ϫ80°C. Five-m-thick sections of paraffin-embedded tissue were prepared for Movat's pentachrome or hematoxylin and eosin stains (Poly Scientific, Bay Shore, NY) and immunohistochemistry studies. Eight-m-thick frozen sections were prepared for Oil Red O staining, Nile Red staining, and immunofluorescence studies.
Whole Lung Protein Extraction, Immunoblotting-The left atrium was cut open, and the lungs were rinsed with 10 ml of PBS injected through the right ventricle and snap-frozen in liquid nitrogen. The lungs were homogenized in 50 mM Tris, pH 7.4, with 150 mM NaCl, 2 mM EDTA, 25 mM NaF, 25 mM ␤-glycerophosphate, 0.1 mM sodium vanadate, 0.2% Triton X-100, 0.3% Nonidet P-40, and 0.1% protease inhibitor mixture (P8340, Sigma) and centrifuged at 13,000 rpm for 15 min. The supernatant was stored at Ϫ20°C. Proteins (10 g) were separated by SDS-PAGE on polyacrylamide gels and transferred onto 0.2-m nitrocellulose membranes (Bio-Rad). Membranes were probed with antibodies targeting SREBP1 (sc-8984, Santa Cruz Biotechnology, Santa Cruz, CA), fatty-acid synthase (FASN) (BD Transduction Laboratories), and GAPDH (A300-641A, Bethyl Laboratories, Montgomery, TX) as a loading con-trol. Band density was analyzed using ImageJ (National Institutes of Health, Bethesda).
Oil Red O Staining-Frozen lung sections or BALF cells were fixed in 4% paraformaldehyde for 15 min and rinsed three times in distilled water. Slides were immersed for 2 min in absolute propylene glycol and incubated for 1 h (BALF cells) or overnight (lung sections) at room temperature in Oil Red O solution (Poly Scientific). Slides were then immersed in 85% propylene glycol, rinsed twice in distilled water, and counterstained with Harris' hematoxylin.
pro-SP-C Immunofluorescence and Nile Red Staining-To identify lipid-laden lung cells, frozen lung sections were rehydrated in PBS, blocked with 4% normal goat serum, and stained with an anti-pro-SP-C antibody (WRAB-SPC, Seven Hills Bioreagents, Cincinnati, OH) followed by an Alexa Fluor 488-conjugated goat anti-rabbit antibody (Invitrogen). Sections were then counterstained for 5 min with 2.5 mg/ml Nile Red in 75% aqueous glycerol and coverslipped. Nile Red fluorescence was analyzed using a 535-580 nm excitation filter and a 591-667 emission filter. With this filter set, fluorescence emitted by Nile Red predominantly reflects neutral lipids over phospholipids. The number of Nile Red-positive cells relative to the number of pro-SP-C-positive cells in five microscopic fields at ϫ10 magnification was determined.
Electron Microscopy-Lungs from 8-week-old mice were fixed in 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer and 0.1% calcium chloride, pH 7.3. Tissue was postfixed in 1% osmium tetroxide, dehydrated, and embedded in epoxy resin (EMbed 812, Electron Microscopy Sciences, Fort Washington, PA). Ultrathin sections were viewed in a Hitachi H7600 transmission electron microscope, and digitized images were collected with an AMT Advantage Plus 2k ϫ 2k digital camera (Advanced Microscopy Techniques, Danvers, MA).
BALF-Mice were anesthetized; the trachea was cannulated, and the lungs were lavaged twice with 1 ml of PBS, pH 7.4. The total number of cells was determined using trypan blue exclusion, and 10,000 cells were plated onto glass slides using a Cytospin centrifuge (Thermo, Waltham, MA) and stained with hematoxylin and eosin for differential counting or kept at Ϫ20°C for Oil Red O staining and immunostaining. In other experiments, BALF cells were lysed, and total RNA was extracted.
Isolation and Sorting of Alveolar Type 2 Cells-Mouse alveolar type 2 cells were isolated as described previously (17) . Briefly, the lungs were perfused to remove blood, inflated with Dispase (Stem Cell Technologies, British Columbia, Canada) for 45 min, and trimmed manually. The resulting suspension was filtered on 100-, 40-, and 20-m filters and incubated for 2 h on 100-mm cultures dishes coated with anti-CD45 and anti-CD16/32 antibodies to eliminate leukocytes. Alveolar type 2 cells were recovered from the supernatant by centrifugation. Total alveolar type 2 cells from 2-month-old animals were used for mRNA microarray and RT-PCR.
Type 2 cells were purified from 6-month-old Insig1/2 ⌬/⌬ mice and subjected to flow cytometry and sorting using the lipid probe Nile Red with an excitation wavelength of 488 nm. Phospholipid-rich cells were sorted using a 660/20 nm emission filter. Neutral lipid-rich cells were sorted using a 545/ 35-nm emission filter (18 Ϫ/Ϫ (n ϭ 3) mice were hybridized to the murine genome 430 2.0 array (Affymetrix, Santa Clara, CA). The RNA quality and quantity assessment, probe preparation, labeling, hybridization, and image scan were carried out in the Cincinnati Children's Hospital Medical Center Affymetrix Core using standard procedures. Data were analyzed using BRB Array Tools software package (linus.nci.nih.gov). Differentially expressed mRNAs were identified using a random variance t test, which permits sharing information among genes about within-class variation without assuming that all genes have the same variance (19) . mRNAs were considered differentially expressed with a p value of Յ0.05 and a fold change of Ն1.5. Affymetrix "Present Call" in at least two of three replicates was set as a prerequisite for gene selection.
Differentially expressed genes were subjected to gene ontology, promoter analysis, and pathway analysis. Gene Ontology analysis was performed using the publicly available web-based tool David (data base for annotation, visualization, and integrated discovery) (21) . Over-represented transcription factorbinding site analyses were performed using 2 kb of promoter sequences upstream of transcription start sites of differentially expressed genes (Genomatix). Gene ontology categories were considered to be significant when a Fisher's exact test p value was Յ0.01 and gene hits were Ն10. Over-represented functions, diseases, known pathways, as well as potential protein/ protein or protein/DNA interactions were identified using ingenuity pathway analysis (Ingenuity). Customized gene networks were constructed by integrating microarray results, literature mining, and experimental observations. Changes in mRNA expression were compared with those obtained in the lungs of Scap-deleted animals (12) . Differentially expressed genes in the Insig deletion array were compared with published gene expression data in the L2L data base.
Lipid Mass Spectrometry Analysis-To assess PC synthesis, turnover, and secretion, animals were injected intraperitoneally 3 h before sacrifice with 6.7 mol of [methyl-9-2 H]choline chloride (CDN Isotopes, Pointe-Claire, Canada). Mice were anesthetized; the trachea was cannulated, and the lungs were lavaged five times with 1 ml of PBS. Lavaged lungs were homogenized in 2 ml of PBS. For lamellar body isolation, lungs were homogenized in 2 ml of 1.2 M sucrose, and the lamellar body fraction was isolated by sucrose gradient density centrifugation as described previously (20) . Lipids were extracted with chloroform and methanol, as described previously (21), from lung homogenate, lamellar bodies, and BALF and from isolated alveolar type 2 cells in an independent experiment. Dimyristoylphosphatidylcholine (PC 14:0/14:0, 15 nmol) and a deuterated triglyceride (glyceryl tri(octadecanoate-18,18,18-d 3 ), CDN Isotopes, 10 nmol) were added as internal standards. The dried lipid extract was divided in two portions for separate electrospray ionization mass spectrometry (ESI-MS) analysis of phospholipids and neutral lipids. PC was analyzed by ESI-MS as described previously (22) Measurement of Lung Mechanics-Lung mechanics were studied in anesthetized and tracheostomized mice using the FlexiVent System (SCIREQ Scientific Respiratory Equipment, Montreal, Quebec, Canada), as described previously (23) . Dynamic resistance, elastance, and compliance of the airways were measured as well as tissue damping, tissue compliance, and tissue hysteresivity.
Statistical Analysis-Data were expressed as means Ϯ S.D. Student's t test was used for comparisons of continuous variables. Association between categorical variables was tested using the 2 test. A p value Ͻ0.05 was considered statistically significant. (Fig. 2A) . The cells were stained with Nile Red, at a fluorescence consistent with neutral lipids, and by pro-SP-C antibody, an alveolar type 2 cell-specific marker (Fig. 2B) (Fig. 3A) wherein large electron lucent lipid droplets were observed (Fig. 3, B and C) . Normal, but smaller, lamellar bodies were present in the cytoplasm of lipid-laden cells. Type 2 epi-thelial cells with normal morphology were also observed, perhaps indicating incomplete deletion of Insig1 in some cells. The morphology of pulmonary lipofibroblasts located in alveolar septa of Insig1/2 ⌬/⌬ mice was unaltered (data not shown), and the ultrastructure of tubular myelin and other forms of secreted surfactant was not changed (data not shown) in Insig1/2 ⌬/⌬ mice, consistent with the preservation of lung function.
RESULTS

Germ Line Deletion of Insig2 or Conditional Deletion of Insig1
Accumulation of Triacylglycerols and Cholesterol Esters in Lungs of Insig1/2
⌬/⌬ Mice-Although there was no difference in total PC concentration in either lung homogenate or isolated type 2 alveolar cells (Fig. 4, A and B) , marked increases in cholesterol esters and triacylglycerols were observed in both fractions for Insig1/2 ⌬/⌬ mice, consistent with the intracellular accumulation of Oil Red O-stained material seen in alveolar type 2 cells of these mice. By contrast, neither neutral lipid was increased in purified lamellar bodies, confirming minimal contamination of this subcellular preparation with lipid vesicles (Fig. 4C) . Although triacylglycerol concentration was not elevated in BALF from Insig1/2 ⌬/⌬ mice, cholesterol esters were significantly increased (Fig. 4D) . Molecular species analysis demonstrated that BALF cholesterol ester composition was very different from that in serum, confirming a local lung synthetic origin in both Insig1/2 ⌬/⌬ (Fig. 4E) and Insig1 flox/flox /Insig2 Ϫ/Ϫ mice (results not shown). The presence of elevated cholesterol ester in BALF combined with its absence in lamellar bodies suggests that, at least in Insig1/ 2 ⌬/⌬ mice, it may either be secreted independently from lamellar bodies or be subject to considerably decreased intra-alveolar catabolism and turnover.
Synthesis de Novo and Secretion of Phosphatidylcholine in Insig1/2
⌬/⌬ Mice-Lipid mass spectrometry analysis revealed significant quantitative and qualitative changes in lung phospholipid contents in Insig1/2 ⌬/⌬ mice. Most strikingly, a 35% (p ϭ 0.002) decrease in total PC was observed in BALF (Fig. 4D) , in contrast to the unchanged total PC content of lung homogenate (Fig. 4A) and alveolar type 2 cells (Fig. 4B) . In addition to the reduction of total PC content in BALF, the relative proportions of individual PC molecular species in all analyzed tissue fractions were significantly altered in Insig1/ 2 ⌬/⌬ mice. In particular, the fractional concentration (% total PC) of the predominant PC16:0/16:0 was consistently but modestly decreased in lung (31. (Fig. 5B) .
In the lungs, synthesis of PC is achieved by a combination of biosynthesis de novo following the Kennedy pathway, with the enzyme choline phosphotransferase (Chpt1) catalyzing the incorporation of CDP-choline with diacylglycerol or by acyl remodeling of unsaturated PC species by two concerted reactions as follows: deacylation of unsaturated PC by a phospholipase A 2 , followed by reacylation of the resultant 1-palmitoyl-2-lysophosphatidylcholine (lyso-PC) with palmitoyl-CoA by lysophosphatidylcholine (lyso-PC) acyltransferase 1 (Lpcat1) (24) . In addition, the final composition of secreted surfactant PC is also modulated by the ABCA3-dependent selection of PC species into lamellar bodies (25) , and also by the specificity of the ABCA1-dependent basolateral secretion of unsaturated PC species from type II alveolar epithelial cells (26) . Consequently, the pattern of incorporation of [methyl-9-2 H]choline into lung PC molecular species will reflect the net sum of all these activities. This pattern was essentially identical to the endogenous PC compositions of whole lung, alveolar type II cells, and lamellar bodies, suggesting that newly synthesized PC in all three compartments was at equilibrium composition with endogenous PC by 3 h (27) . By contrast, the composition of newly synthesized PC secreted into BALF was, for both Insig1 flox/flox / Insig2 Ϫ/Ϫ and Insig1/2 ⌬/⌬ mice, enriched in unsaturated PC species containing 18 carbon atoms or greater, compared with the total BALF PC composition (Fig. 5C) . A proportion of newly synthesized surfactant PC is secreted before the processes of acyl remodeling and completion of species selection, suggesting a similar initial elevated fractional synthesis of long chain unsaturated PC species in both groups of mice. The major difference caused by deletion of Insig1/2 was the increased fractional content and label incorporation of PC16:0/16:1 in BALF PC from Insig1/2 ⌬/⌬ mice at the expense of decreased content and incorporation into PC16:0/16:0. As lamellar bodies can select and package PC16:0/16:1 equally well as PC16:0/16:0 (24), this contrasting specificity suggests that the altered PC composition in Insig1/2 ⌬/⌬ mice was possibly due to altered specificity of acyl remodeling related to increased substrate CoA16:1 as a consequence of increased expression of Scd1 (Fig.  7B) . Altered activity of the acyl remodeling pathway would be expected to alter the kinetics of lyso-PC labeling, but neither the concentration nor the [methyl-9-2 H]choline labeling of lyso-PC in lung tissue were altered by Insig deletion (data not shown). Although BALF PC16:0/16:0 was decreased, lung mechanics were similar in 6-month-old Insig1/2 ⌬/⌬ mice and 
Insig1
flox/flox /Insig2 Ϫ/Ϫ mice (data not shown), indicating maintenance of surfactant activity. (Fig. 6A) . Of the 469 induced mRNAs, 99 were related to lipid metabolism. mRNAs encoding proteins regulating fatty acid synthesis, acyl chain elongation, and cholesterol biosynthesis were increased in alveolar type 2 cells from the Insig1/2 ⌬/⌬ mice. Approximately 100 mRNAs related to inflammatory processes were increased in the Insig1/ 2 ⌬/⌬ mice ( Fig. 10 and supplemental Table 2 ). Decreased expression of Insig1 and increased expression of Hmgcs1, Fasn, and Stard4 were verified by RT-PCR (Fig. 6B) . Consistent with RNA microarray data, Western blot analyses (Fig. 6C) indicated that FASN was significantly increased in Insig1/2 ⌬/⌬ lungs (9.5-fold increase, p ϭ 0.0004). Although LPCAT1 activity was not measured, LPCAT1 mRNA was not altered (p ϭ 0.38), consistent with preservation of acyl chain remodeling seen in the analysis of lung lipids.
RNA Microarray Analysis Revealed Activation of Fatty Acid and Cholesterol Biosynthetic Pathways in
According to Gene Ontology classification, the biological processes most induced by deletion of Insig1/2 in type 2 cells were related to "immunity and defense," "lipid, fatty acid, and steroid metabolism," "macrophage-mediated immunity," "cytokine-and chemokine-mediated signaling pathway," "T-cell mediated immunity," and "cholesterol metabolism." mRNA expression profiles from Insig1/2 ⌬/⌬ mice were compared with those in which SREBP was inhibited by deletion of Scap in type 2 cells (12) . We identified 30 mRNAs that were both induced by Insig deletion and decreased by Scap deletion (supplemental Table 2 ). These genes were highly enriched in pathways regulating lung "lipid metabolism," e.g. fatty acid biosynthesis, metabolism, steroid synthesis, and liver X receptor/RXR activation, many of which are regulated by SREBP in liver or lung, consistent with the important role of the SREBP pathways in lipid metabolism. A number of genes in this list, including Abca1, Fasn, Fdft1, Hmgcr, Lpin1, Rora, Srebf1, and Steap2, are known to be associated with dyslipidemia, a disorder of high cholesterol and high blood triglycerides and hypercholesterolemia.
Gene Expression Profile of Alveolar Type 2 Cell Subpopulations-Because ultrastructural studies identified subsets of cells that either were lipid-laden or normal in appearance, subpopulations of alveolar type 2 cells were sorted according to their neutral lipid content (Fig. 7A) . Insig1/2 ⌬/⌬ neutral-lipid (Fig. 7C) . A number of mRNAs were induced in NL Ϫ alveolar type 2 cells in the Insig1/2 ⌬/⌬ mice, perhaps indicating an adaptive response to the induction of lipid synthesis caused by deletion of Insigs. These mRNAs included Fabp4 (a lipid transporter), Lipa (a lipid catabolism enzyme), and proinflammatory molecules Cxcl3, Ccl6, and Il1b (Fig. 7D) .
Analysis of the promoter regions of the group of genes induced in the NL ϩ versus NL Ϫ cells identified SREBP as the most enriched common regulatory cis-element in the NL
) cells (p ϭ 3.17E-13), whereas the promoters of genes induced in NL Ϫ (nondeleted) cells were enriched in common cis-elements for peroxisome proliferator-activated receptor/RXR (p ϭ 5.51E-04) and TR4 (NR2C2, p ϭ 2.73E-05), a member of nuclear receptor subfamily 2 known to inhibit peroxisome proliferator-activated receptor ␣/RXR␣ (27) . The genes altered in NL ϩ cells are likely to represent direct effects of insulin-induced gene/SREBP. In contrast, mRNAs induced in NL Ϫ type II cells may represent compensatory responses regulated in part via peroxisome proliferator-activated receptor/ RXR signaling.
Differentially expressed genes identified after Insig1/2 deletion were similar to those in lungs of lysosomal acid lipase (Lipa) knock-out mice (28) . LIPA hydrolyzes triglycerides and cholesterol esters in lysosomes. Phenotypic changes in Insig1/ 2 ⌬/⌬ mice share similarities with the Lipa Ϫ/Ϫ mice, including accumulation of triglycerides and cholesterol esters in type II cells, progressive inflammation, foamy macrophages, lung remodeling, and epithelial hyperplasia (29) . In humans, mutation of LIPA causes Wolman disease a cholesterol ester storage disease in which cholesterol esters and triglycerides accumulate in most tissues (30) . In this study, Lipa mRNA was significantly reduced in NL ϩ and induced in NL Ϫ cells, correlating with Insig1 mRNA levels in the two subpopulations of type II cells. We speculate that reduction of Lipa mRNA contributes to the accumulation of cholesterol esters and triglycerides in Insig1/2-deficient type II cells. The expression of mRNAs encoding a number of lipid transport proteins was increased in Insig1 ⌬/⌬ /Insig2 Ϫ/Ϫ alveolar type 2 cells, including Abca3, Abcg1, Abca1, Stard4, and Stard2 (supplemental Table 2A ) (31) (32) (33) .
Inflammation in Lungs of Insig1/2 ⌬/⌬ Mice-Although inflammatory infiltrates were not observed in lung sections of 2-month-old Insig-deficient mice, mRNA levels of many inflammatory response genes were moderately induced in type II epithelial cells isolated from the mice (Fig. 6 and supplemental Table 2 ). RNAs associated with the IL-12 signaling pathway were modestly but significantly induced, including Infg, Il-12b, Irf8, Stat4, and Stat5a mRNAs. Increased expression of mRNAs encoding a number of cytokines, chemokines, and associated receptors and transcriptional regulators was observed, consistent with a proinflammatory environment caused by deletion of Insig1/2. At 6 months of age, focal inflammatory lesions were evident in the lungs of Insig1/2 ⌬/⌬ but not in Insig1 flox/flox / Insig2 Ϫ/Ϫ mice. Accumulation of foamy and multinucleated macrophages was observed in the alveoli and interstitium in 67% of Insig1/2 ⌬/⌬ mice (p ϭ 0.016, 2 test, see Fig. 8A ). Lymphocyte infiltration was shown by CD3 immunostaining in 40% of Insig1/2 ⌬/⌬ mice (p ϭ 0.078, 2 test, see Fig. 8B ). Moreover, inflammatory changes were accompanied by alveolar type 2 cell hyperplasia in Insig1/2 ⌬/⌬ mice, as shown by pro-SP-C immunostaining (Fig. 8C) . Extensive pulmonary pathology was observed in older Insig1/2-deficient mice (8 -9 months), and alveoli were filled with lipids, foamy macrophages, and cholesterol crystals (Fig. 8D) .
Numbers of BALF cells were markedly increased in Insig1/ 2 ⌬/⌬ compared with Insig1 flox/flox /Insig2 Ϫ/Ϫ mice at 2 and 6 months of age (Fig. 9A and data not shown) . BALF cells were predominantly (99%) monocytes/macrophages in both genotypes. At 2 and 6 months of age, lipid-laden macrophages as shown by Oil Red O staining were increased (Fig. 9B) . The atypical alveolar macrophages stained for anti-arginase1, a marker of alternative macrophage activation, in Insig1/2 ⌬/⌬ mice (14.8 Ϯ 4%) compared with controls (3 Ϯ 1.9%, p ϭ 0.028, Fig.  9C ), and expressed high levels of Arg1 mRNA but low levels of Nos2 mRNA (Fig. 9D) . BALF PGE 2 , IL4, IL10, IL13, and IFN-␥ levels were similar in both groups of mice (data not shown). Concentrations of cytokines and chemokines associated with inflammation in diabetes and obesity were assessed in lung homogenates at 8 weeks of age (Fig. 9F ). IL-6 and keratinocyte chemoattractant concentrations were significantly increased in the Insig1/-deleted mice, consistent with the inflammation seen histologically. Likewise, IL-1B and IL-12B mRNAs in alveolar macrophages isolated from BALF were significantly increased at this age (Fig. 9G) . Table 2 ) (31) (32) (33) 35) , which may represent a direct response of SREBP activation to handle the increased lipid accumulation. The mRNAs regulating lipid biosynthetic pathways activated by Insig deletion in the lung were similar to those induced by Insig deletion in the liver; nevertheless, quantitative differences were evident between the two organs. In the liver, Insig deletion led to moderate increases in mRNAs coding enzymes involved in cholesterol synthesis (Hmgcs1, 1.2-fold; Hmgcr, 2-fold; Ldlr, 1.2-fold), whereas mRNAs coding enzymes involved in fatty acid synthesis were markedly increased (Acaca, 2.7-fold; Fasn, 4.5-fold). A distinct expression profile was observed after Insig1/2 deletion in the lung, as mRNAs encoding protein in both cholesterol and phospholipid biosynthetic pathways were similarly but modestly induced. These results show that transcriptional responses to SREBPs follow organ-specific patterns. Fig. 10 (Fig. 7) , genes known to regulate surfactant lipid and protein synthesis in the developing lung, indicates a potential compensatory response by by mass spectrometry. Both triglycerides and cholesterol ester were increased in lung tissue but not in lamellar bodies isolated by differential centrifugation from the Insig-deleted mice. Combined with the unaltered triacylglycerol profile in BALF, these results support the presence of distinct pathways organizing neutral lipid storage and lamellar body formation in alveolar type 2 cells. Furthermore, the increased cholesterol ester concentration in BALF but not in lamellar bodies (Fig. 4D ) also suggests that neutral lipids in BALF have a different intracellular origin in type 2 alveolar cells other than from surfactant lamellar bodies. The accumulation of triglycerides in the lungs of Insig-deficient mice was not associated with increases in the expression levels of Dgat1 or Dgat2 in alveolar type 2 cells, the enzymes mediating triglyceride synthesis.
In sharp contrast to mice in which other members of the transcriptional network controlling alveolar type 2 cell surfactant lipid homeostasis, e.g. Foxa2, Nfatc3, Cebpa, and Nkx2-1, were deleted or mutated in the respiratory epithelium (36 -39) , deletion of Insig genes and activation of SREBP did not impair lung formation and maturation. Surfactant function was maintained despite increased SREBP activity and its activation of nonsurfactant lipogenic pathways. The distinct gene expression profiles seen in the subpopulation of deleted and nondeleted alveolar type 2 cells in Insig1 ⌬/⌬ mice supports metabolic compensation within and between type 2 cells. Increased numbers and associated lipid catabolic activity of alveolar macrophages in the Insig-deficient mice likely contribute to the increased lung lipid clearance in Insig1/2 ⌬/⌬ mice, consistent Ϫ/Ϫ and Insig1/2 ⌬/⌬ mice, n ϭ 6; *, p Ͻ 0.05. mRNA was isolated from alveolar macrophages isolated after lung lavage from 8-week-old control (n ϭ 10) and Insig1/2 ⌬/⌬ mice, n ϭ 5. G, IL-1b and IL-12b mRNAs were measured by RT-PCR and were normalized to 18 S RNA levels. Bars represent means Ϯ S.D., and differences were assessed by two-tailed Student t test.
with the important role of alveolar macrophages in lung lipid homeostasis. The unaltered surfactant PC content in lungs of Insig1/2 ⌬/⌬ mice was consistent with preserved expression of proteins known to be essential for lamellar body formation and secretion, for example Sftpb or Abca3, the latter being induced by deletion of Insigs.
The focal accumulation of giant foamy multinucleated macrophages in the alveolar spaces and airspace remodeling was a striking feature of older Insig1/2 ⌬/⌬ mice. This phenomenon is also observed in other models of lung lipid overload, as seen in mice bearing deletion of the Sftpd (40) or Abcg1 (41) genes and in mice with mutations of the Hps1 or Ap3 genes that model the Hermanski-Pudlak syndrome in humans (42) .
Lipid accumulation and pulmonary infiltration with lipidladen macrophages increased with age in the Insig-deleted mice. In Insig1/2 ⌬/⌬ mice, alveolar macrophages had morphological and functional characteristics consistent with macrophage activation. IL-6 and keratinocyte chemoattractant levels were increased in lung tissue, consistent with the mRNA microarray data from alveolar type II cells isolated from the Insig1/2 ⌬/⌬ mice. Pathway enrichment analysis supports the concept that macrophages were activated via an IL-12/STAT4/ IFNG signaling cascade. Supporting this concept, expression of IL-12B and IL-1B mRNAs was increased in alveolar macrophages isolated from the Insig1/2-deleted mice. mRNAs encoding proteins in the IL-12/STAT4-dependent signaling pathways were significantly induced in Insig1/2 ⌬/⌬ mice, including Il12b, Il18, Stat4, Stat5a, Ifng, Ccr5, Irf1, and Selp. In contrast, expression of Th2-type cytokines IL-4 and IL-13, indicators of Th2 activation, was not changed. Although mechanisms by which both epithelial and macrophage activation and focal alveolar remodeling occurs in this study are unclear, there is increasing evidence that excess lipid accumulation in tissues recruits and activates macrophages.
The present findings are also consistent with the studies in Abcg1 gene-deleted mice in which cholesterol and phospholipids accumulate in both type II cells and alveolar macrophages causing inflammation. Changes in expression of pro-inflammatory cytokines and chemokine-associated pathways in lungs from Abcg1 Ϫ/Ϫ mice are similar to those induced by deletion of Insig1/2, including increased mRNAs encoding Ccl 5-9,17,22, Cxdl 3,5, and chemokine receptors Ccr 5-7, Infg, and Tgf␤1. In vitro loading of human monocyte-derived macrophages with cholesterol directly induces the expression of IL-1␤ (43) . Thus, in the present model, excessive synthesis of cholesterol and other neutral lipids in the type II epithelial cells caused lipid accumulation in both epithelial cells and alveolar macrophages. Although lipid synthetic pathways were induced in Insig1/2-deleted alveolar type II cells, Cxcl3, Ccl6, and Il-1␤ mRNAs were induced in the nondeleted cells and in alveolar macrophages (Fig. 7) , indicating that both alveolar macrophages and epithelial cells likely contribute to the inflammation and remodeling seen in the Insig1/2-deleted mice. Fig. 10 provides a proposed gene network linking changes in lipogenesis and lung inflammation observed in the Insig1/2-deleted mice.
Pulmonary inflammation and lung dysfunction is associated with diabetes mellitus, obesity, and in lipid storage disorders (14) . Likewise, lung dysfunction, inflammation, and remodeling are associated with lipid droplet accumulation in lungs of diabetic Zucker rats (44) . Taken together, the accumulation of neutral lipids related to enhanced lung lipid synthesis or content may represent a form of pulmonary lipotoxicity similar to that associated with obesity and diabetes (45) (46) .
